BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 2015;17:1029-38. [PMID: 25838139 DOI: 10.1093/neuonc/nov044] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Cohen LE. Update on childhood craniopharyngiomas: . Current Opinion in Endocrinology & Diabetes and Obesity 2016;23:339-44. [DOI: 10.1097/med.0000000000000264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
2 Yang J, Hou Z, Wang C, Wang H, Zhang H. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma. Cancer Gene Ther 2018;25:227-39. [PMID: 29681617 DOI: 10.1038/s41417-018-0015-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
3 Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Kleinschmidt-DeMasters BK, Handler MH, Tan AC, Gore L, Virasami A, Gonzalez-Meljem JM, Jacques TS, Martinez-Barbera JP, Foreman NK, Hankinson TC; Advancing Treatment for Pediatric Craniopharyngioma Consortium. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma. J Neuropathol Exp Neurol 2017;76:779-88. [PMID: 28859336 DOI: 10.1093/jnen/nlx061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 6.4] [Reference Citation Analysis]
4 Zoli M, Sambati L, Milanese L, Foschi M, Faustini-Fustini M, Marucci G, de Biase D, Tallini G, Cecere A, Mignani F, Sturiale C, Frank G, Pasquini E, Cortelli P, Mazzatenta D, Provini F. Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas. Neurosurg Focus 2016;41:E12. [PMID: 27903128 DOI: 10.3171/2016.9.FOCUS16317] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
5 Hamblin R, Tsermoulas G, Karavitaki N. Craniopharyngiomas. Presse Med 2021;50:104078. [PMID: 34688870 DOI: 10.1016/j.lpm.2021.104078] [Reference Citation Analysis]
6 Jung HW, Kim HY, Kim JY, Cheon JE, Kim IO, Kim SK, Shin CH, Yang SW, Lee YA. Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma. PLoS One 2021;16:e0246789. [PMID: 33591998 DOI: 10.1371/journal.pone.0246789] [Reference Citation Analysis]
7 Jensterle M, Jazbinsek S, Bosnjak R, Popovic M, Zaletel LZ, Vesnaver TV, Kotnik BF, Kotnik P. Advances in the management of craniopharyngioma in children and adults. Radiol Oncol 2019;53:388-96. [PMID: 31652121 DOI: 10.2478/raon-2019-0036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
8 van Schaik J, Begijn DGA, van Iersel L, Vergeer Y, Hoving EW, Peeters B, van Santen HM. Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity. Obes Facts 2020;13:361-70. [PMID: 32781455 DOI: 10.1159/000509302] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Müller HL. Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary 2017;20:267-81. [DOI: 10.1007/s11102-016-0751-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenbüchel AM, Eveslage M, Müller HL. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J Endocrinol 2015;173:853-62. [PMID: 26392473 DOI: 10.1530/EJE-15-0709] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 4.4] [Reference Citation Analysis]
11 van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, van Santen HM. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review. Endocr Rev 2019;40:193-235. [PMID: 30247642 DOI: 10.1210/er.2018-00017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
12 Jung SY, Lee YJ, Lee HJ, Lee YA, Moon JS, Ko JS, Yang SW, Shin CH. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Ann Pediatr Endocrinol Metab 2017;22:189-96. [PMID: 29025206 DOI: 10.6065/apem.2017.22.3.189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Seo GH, Choi JH, Kim YM, Koh KN, Im HJ, Ra YS, Yoo HW. Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors. J Neurooncol 2018;138:55-62. [PMID: 29352447 DOI: 10.1007/s11060-018-2765-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Amayiri N, Spitaels A, Zaghloul M, Figaji A, Cavalheiro S, Muller HL, Elhassan M, Parkes J, Mushtaq N, Beltagy ME, Yousef YA, Esiashvili N, Sullivan M, da Costa MD, Dastoli P, Mubarak F, Bartels U, Chamdine O, Davidson A, Musharbash A, Alcasabas P, Bouffet E, Bailey S. SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings. Pediatr Blood Cancer 2020;:e28493. [PMID: 32790146 DOI: 10.1002/pbc.28493] [Reference Citation Analysis]
15 Zhou Z, Zhang S, Hu F. Endocrine Disorder in Patients With Craniopharyngioma. Front Neurol 2021;12:737743. [PMID: 34925209 DOI: 10.3389/fneur.2021.737743] [Reference Citation Analysis]
16 Dogra P, Bedatsova L, Van Gompel JJ, Giannini C, Donegan DM, Erickson D. Long-term outcomes in patients with adult-onset craniopharyngioma. Endocrine. [DOI: 10.1007/s12020-022-03134-4] [Reference Citation Analysis]
17 Sterkenburg AS, Hoffmann A, Reichel J, Lohle K, Eveslage M, Warmuth-Metz M, Müller HL. Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma. J Clin Endocrinol Metab 2016;101:4922-30. [PMID: 27680877 DOI: 10.1210/jc.2016-2547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Heinks K, De Schutter-Nüsse C, Boekhoff S, Bogusz A, Zhu J, Peng J, Müller HL. Periostin concentrations in childhood-onset craniopharyngioma patients. J Endocrinol Invest 2019;42:815-24. [PMID: 30474798 DOI: 10.1007/s40618-018-0987-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Jastania RA, Saeed M, Al-Khalidi H, AlQuthami K, Nageeti TH, Al-Allaf FA, Valerie K, Taher MM. Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis. Int Med Case Rep J 2020;13:123-37. [PMID: 32368160 DOI: 10.2147/IMCRJ.S243405] [Reference Citation Analysis]
20 Ma G, Kang J, Qiao N, Zhang B, Chen X, Li G, Gao Z, Gui S. Non-Invasive Radiomics Approach Predict Invasiveness of Adamantinomatous Craniopharyngioma Before Surgery. Front Oncol 2020;10:599888. [PMID: 33680925 DOI: 10.3389/fonc.2020.599888] [Reference Citation Analysis]
21 Hoffmann A, Bootsveld K, Gebhardt U, Daubenbüchel AM, Sterkenburg AS, Müller HL. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J Endocrinol 2015;173:389-97. [PMID: 26088821 DOI: 10.1530/EJE-15-0422] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
22 Aridgides P, Janssens GO, Braunstein S, Campbell S, Poppe M, Murphy E, MacDonald S, Ladra M, Alapetite C, Haas-Kogan D. Gliomas, germ cell tumors, and craniopharyngioma. Pediatr Blood Cancer 2021;68 Suppl 2:e28401. [PMID: 32960496 DOI: 10.1002/pbc.28401] [Reference Citation Analysis]
23 Jung D, Seo GH, Kim YM, Choi JH, Yoo HW. Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. Ann Pediatr Endocrinol Metab 2018;23:51-5. [PMID: 29609450 DOI: 10.6065/apem.2018.23.1.51] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bogusz A, Müller HL. Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up. Expert Review of Neurotherapeutics 2018;18:793-806. [DOI: 10.1080/14737175.2018.1528874] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
25 Müller HL. Management of Hypothalamic Obesity. Endocrinol Metab Clin North Am 2020;49:533-52. [PMID: 32741487 DOI: 10.1016/j.ecl.2020.05.009] [Reference Citation Analysis]
26 Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [DOI: 10.12998/wjcc.v10.i18.6211] [Reference Citation Analysis]
27 Whelan R, Hengartner A, Folzenlogen Z, Prince E, Hankinson TC. Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review. Childs Nerv Syst 2020;36:1635-42. [DOI: 10.1007/s00381-020-04677-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Di Somma C, Scarano E, Barrea L, Solari D, Riccio E, Arianna R, Cavallo LM, Romano F, Di Benedetto E, Rodriguez A, de Alteriis G, Colao A. Craniopharyngioma, Chronotypes and Metabolic Risk Profile. Nutrients 2021;13:3444. [PMID: 34684445 DOI: 10.3390/nu13103444] [Reference Citation Analysis]
29 Yang L, Xie S, Tang B, Wu X, Tong Z, Fang C, Ding H, Bao Y, Zheng S, Hong T. Hypothalamic injury patterns after resection of craniopharyngiomas and correlation to tumor origin: A study based on endoscopic observation. Cancer Med 2020;9:8950-61. [PMID: 33141521 DOI: 10.1002/cam4.3589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Hankinson TC, Kleinschmidt-DeMasters BK. Adamantinomatous craniopharyngioma and xanthomatous lesions of the sella. Brain Pathol 2017;27:356-7. [PMID: 28236347 DOI: 10.1111/bpa.12497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Kang J, Cao L, Yuan T, Jin L, Shi Y, Ma G, Qiao N, Li C, Zhang Y, Zuo Z, Gui S. Predicting the location of the preoptic and anterior hypothalamic region by visualizing the thermoregulatory center on fMRI in craniopharyngioma using cold and warm stimuli. Aging (Albany NY) 2021;13:10087-98. [PMID: 33818420 DOI: 10.18632/aging.202766] [Reference Citation Analysis]
32 Hu W, Qiu B, Mei F, Mao J, Zhou L, Liu F, Fan J, Liu Y, Wen G, Qi S, Bao Y, Pan J. Clinical impact of craniopharyngioma classification based on location origin: a multicenter retrospective study. Ann Transl Med 2021;9:1164. [PMID: 34430605 DOI: 10.21037/atm-21-2924] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wu J, Fu J, Huang ZJ, Xie SH, Tang B, Wu X, Tong ZG, Wu BW, Pan CB, Yang YQ, Ding H, Li SY, Qi JL, Hong T. Postoperative hypothalamic damage predicts postoperative weight gain in patients with adult-onset craniopharyngioma. Obesity (Silver Spring) 2022. [PMID: 35707874 DOI: 10.1002/oby.23447] [Reference Citation Analysis]
34 Erfurth EM. Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma. Neuroendocrinology 2020;110:767-79. [PMID: 32580186 DOI: 10.1159/000509616] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
35 Romigi A, Feola T, Cappellano S, De Angelis M, Pio G, Caccamo M, Testa F, Vitrani G, Centonze D, Colonnese C, Esposito V, Jaffrain-rea M. Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update. Front Neurol 2022;12:817257. [DOI: 10.3389/fneur.2021.817257] [Reference Citation Analysis]
36 Hollon TC, Savastano LE, Altshuler D, Barkan AL, Sullivan SE. Ventriculoscopic Surgery for Cystic Retrochiasmatic Craniopharyngiomas: Indications, Surgical Technique, and Short-Term Patient Outcomes. Oper Neurosurg (Hagerstown) 2018;15:109-19. [PMID: 29048572 DOI: 10.1093/ons/opx220] [Reference Citation Analysis]
37 Boekhoff S, Bison B, Eveslage M, Sowithayasakul P, Müller HL. Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007. Pituitary 2019;22:532-41. [PMID: 31440945 DOI: 10.1007/s11102-019-00983-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
38 Chen M, Zheng SH, Liu Y, Shi J, Qi ST. Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma. J Neurol Sci 2016;360:49-54. [PMID: 26723972 DOI: 10.1016/j.jns.2015.11.042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
39 Memmesheimer RM, Lange K, Dölle M, Heger S, Mueller I. Psychological well-being and independent living of young adults with childhood-onset craniopharyngioma. Dev Med Child Neurol 2017;59:829-36. [DOI: 10.1111/dmcn.13444] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
40 Müller HL. MANAGEMENT OF ENDOCRINE DISEASE: Childhood-onset craniopharyngioma: state of the art of care in 2018. Eur J Endocrinol 2019;180:R159-74. [PMID: 30817319 DOI: 10.1530/EJE-18-1021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 9.5] [Reference Citation Analysis]
41 Guimarães MM, Cardeal DD, Teixeira MJ, Lucio JEDC, Sanders FH, Kuromoto RK, Matushita H. Brachytherapy in paediatric craniopharyngiomas: a systematic review and meta-analysis of recent literature. Childs Nerv Syst 2021. [PMID: 34618201 DOI: 10.1007/s00381-021-05378-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Duan D, Wehbeh L, Mukherjee D, Hamrahian AH, Rodriguez FJ, Gujar S, Khalafallah AM, Hage C, Caturegli P, Gallia GL, Ahima RS, Maruthur NM, Salvatori R. Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma. J Clin Endocrinol Metab 2021;106:e1603-17. [PMID: 33417676 DOI: 10.1210/clinem/dgaa985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Schulte F, Russell KB, Cullen P, Embry L, Fay-mcclymont T, Johnston D, Rosenberg AR, Sung L. Systematic review and meta-analysis of health-related quality of life in pediatric CNS tumor survivors: Schulte et al. Pediatr Blood Cancer 2017;64:e26442. [DOI: 10.1002/pbc.26442] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
44 Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers 2019;5:75. [PMID: 31699993 DOI: 10.1038/s41572-019-0125-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
45 Jacola LM, Conklin HM, Scoggins MA, Ashford JM, Merchant TE, Mandrell BN, Ogg RJ, Curtis E, Wise MS, Indelicato DJ, Crabtree VM. Investigating the Role of Hypothalamic Tumor Involvement in Sleep and Cognitive Outcomes Among Children Treated for Craniopharyngioma. J Pediatr Psychol 2016;41:610-22. [PMID: 27189690 DOI: 10.1093/jpepsy/jsw026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
46 Hoffmann A, Özyurt J, Lohle K, Reichel J, Thiel CM, Müller HL. First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma. Endocrine 2017;56:175-85. [PMID: 28213803 DOI: 10.1007/s12020-017-1257-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
47 Rey-casserly C, Diver T. Late effects of pediatric brain tumors. Current Opinion in Pediatrics 2019;31:789-96. [DOI: 10.1097/mop.0000000000000837] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
48 Hokken-Koelega A, van der Lely AJ, Hauffa B, Häusler G, Johannsson G, Maghnie M, Argente J, DeSchepper J, Gleeson H, Gregory JW, Höybye C, Keleştimur F, Luger A, Müller HL, Neggers S, Popovic-Brkic V, Porcu E, Sävendahl L, Shalet S, Spiliotis B, Tauber M. Bridging the gap: metabolic and endocrine care of patients during transition. Endocr Connect 2016;5:R44-54. [PMID: 27803155 DOI: 10.1530/EC-16-0028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
49 Christen S, Roser K, Mulder RL, Ilic A, Lie HC, Loonen JJ, Mellblom AV, Kremer LCM, Hudson MM, Constine LS, Skinner R, Scheinemann K, Gilleland Marchak J, Michel G; IGHG psychological late effects group. Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. J Cancer Surviv 2020;14:923-38. [PMID: 32839902 DOI: 10.1007/s11764-020-00904-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
50 Steinbok P. Craniopharyngioma in Children: Long-term Outcomes. Neurol Med Chir (Tokyo) 2015;55:722-6. [PMID: 26345668 DOI: 10.2176/nmc.ra.2015-0099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
51 Wu J, Pan C, Xie S, Tang B, Fu J, Wu X, Tong Z, Wu B, Yang Y, Ding H, Li S, Hong T. A propensity-adjusted comparison of endoscopic endonasal surgery versus transcranial microsurgery for pediatric craniopharyngioma: a single-center study. J Neurosurg Pediatr 2021;:1-10. [PMID: 34920437 DOI: 10.3171/2021.10.PEDS21392] [Reference Citation Analysis]
52 Conti A, Pontoriero A, Ghetti I, Senger C, Vajkoczy P, Pergolizzi S, Germanò A. Benefits of image-guided stereotactic hypofractionated radiation therapy as adjuvant treatment of craniopharyngiomas. A review. Childs Nerv Syst 2019;35:53-61. [PMID: 30151751 DOI: 10.1007/s00381-018-3954-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
53 Romijn JA. The chronic syndromes after previous treatment of pituitary tumours. Nat Rev Endocrinol 2016;12:547-56. [DOI: 10.1038/nrendo.2016.84] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
54 Henderson F Jr, Schwartz TH. Update on management of craniopharyngiomas. J Neurooncol 2022;156:97-108. [PMID: 34807341 DOI: 10.1007/s11060-021-03906-4] [Reference Citation Analysis]
55 Daubenbüchel AMM, Hoffmann A, Eveslage M, Özyurt J, Lohle K, Reichel J, Thiel CM, Martens H, Geenen V, Müller HL. Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine 2016;54:524-31. [DOI: 10.1007/s12020-016-1084-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
56 Park HJ, Dho Y, Kim JH, Kim JW, Park C, Kim YH. Recurrence Rate and Prognostic Factors for the Adult Craniopharyngiomas in Long-Term Follow-Up. World Neurosurgery 2020;133:e211-7. [DOI: 10.1016/j.wneu.2019.08.209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
57 Hidalgo ET, Orillac C, Kvint S, Mcquinn MW, Dastagirzada Y, Phillips S, Wisoff JH. Quality of life, hypothalamic obesity, and sexual function in adulthood two decades after primary gross-total resection for childhood craniopharyngioma. Childs Nerv Syst 2020;36:281-9. [DOI: 10.1007/s00381-019-04161-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
58 Otte A, Müller HL. Mini-review: Childhood-onset Craniopharyngioma. J Clin Endocrinol Metab 2021:dgab397. [PMID: 34086900 DOI: 10.1210/clinem/dgab397] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Müller HL. Bariatric Interventions in Craniopharyngioma Patients-Best Choice or Last Option for Treatment of Hypothalamic Obesity? J Clin Endocrinol Metab 2022;107:e426-8. [PMID: 34331765 DOI: 10.1210/clinem/dgab567] [Reference Citation Analysis]
60 Müller HL. Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma. Expert Review of Neurotherapeutics 2016;16:535-48. [DOI: 10.1586/14737175.2016.1166959] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
61 Amayiri N, Swaidan M, Yousef Y, Halalsheh H, Abu-Hijlih R, Kalaldeh S, Barbar M, Elayyan M, Faqih N, Al-Hussaini M, Mehyar M, Bartels U, Drake J, Musharbash A, Bouffet E. Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience. Childs Nerv Syst 2017;33:941-50. [PMID: 28455541 DOI: 10.1007/s00381-017-3411-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Johnson AH, Rodgers Phillips S, Rice M. Abnormal weight gain with fatigue and stress in early survivorship after childhood brain tumor diagnosis. J Spec Pediatr Nurs 2020;25:e12288. [PMID: 32065725 DOI: 10.1111/jspn.12288] [Reference Citation Analysis]
63 Mehren A, Özyurt J, zu Klampen P, Boekhoff S, Thiel CM, Müller HL. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol 2018;140:27-35. [DOI: 10.1007/s11060-018-2936-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
64 Daubenbüchel AM, Özyurt J, Boekhoff S, Warmuth-Metz M, Eveslage M, Müller HL. Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement. Pediatr Obes 2019;14:e12527. [PMID: 31013553 DOI: 10.1111/ijpo.12527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
65 O'steen L, Indelicato DJ. Advances in the management of craniopharyngioma. F1000Res 2018;7:F1000 Faculty Rev-1632. [PMID: 30363774 DOI: 10.12688/f1000research.15834.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
66 Hoffmann A, Warmuth-Metz M, Lohle K, Reichel J, Daubenbüchel AM, Sterkenburg AS, Müller HL. Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome. Pituitary 2016;19:422-8. [PMID: 27125511 DOI: 10.1007/s11102-016-0722-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
67 Xu Y, Xu L, Chen X, Sun P, Guo Q, Wang H. Bitter melon seed oil may reduce the adiposity through the hypothalamus mTOR signaling in mice fed a high fat diet. Journal of Nutrition & Intermediary Metabolism 2016;6:16-21. [DOI: 10.1016/j.jnim.2016.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Yang L, Xie SH, Fang C, Zeng EM, Tang B, Hong T. Preservation of Hypothalamic Function with Endoscopic Endonasal Resection of Hypothalamus-Invaded Craniopharyngiomas. World Neurosurg 2019;132:e841-51. [PMID: 31398519 DOI: 10.1016/j.wneu.2019.07.225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
69 Tan TSE, Patel L, Gopal-Kothandapani JS, Ehtisham S, Ikazoboh EC, Hayward R, Aquilina K, Skae M, Thorp N, Pizer B, Didi M, Mallucci C, Blair JC, Gaze MN, Kamaly-Asl I, Spoudeas H, Clayton PE. The neuroendocrine sequelae of paediatric craniopharyngioma: a 40-year meta-data analysis of 185 cases from three UK centres. Eur J Endocrinol 2017;176:359-69. [PMID: 28073908 DOI: 10.1530/EJE-16-0812] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 5.6] [Reference Citation Analysis]
70 Tso WWY, Liu APY, Lee TMC, Cheuk KL, Shing MK, Luk CW, Ling SC, Ku DTL, Li K, Yung AWY, Fung CW, Chan SHS, Ho ACC, Ho FKW, Ip P, Chan GCF. Neurocognitive function, performance status, and quality of life in pediatric intracranial germ cell tumor survivors. J Neurooncol 2019;141:393-401. [DOI: 10.1007/s11060-018-03045-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
71 Castle-Kirszbaum M, Shi MDY, Goldschlager T. Quality of Life in Craniopharyngioma: A Systematic Review. World Neurosurg 2022:S1878-8750(22)00669-6. [PMID: 35580780 DOI: 10.1016/j.wneu.2022.05.038] [Reference Citation Analysis]
72 Müller HL. Long-Term Management and Clinical Trials in Adamantinomatous Craniopharyngioma. In: Martinez-barbera JP, Lilian Andoniadou C, editors. Basic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma. Cham: Springer International Publishing; 2017. pp. 179-214. [DOI: 10.1007/978-3-319-51890-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
73 Dimitri P. Treatment of Acquired Hypothalamic Obesity: Now and the Future. Front Endocrinol 2022;13:846880. [DOI: 10.3389/fendo.2022.846880] [Reference Citation Analysis]
74 Wang KW, Valencia M, Banfield L, Chau R, Fleming A, Singh SK, Burrow S, de Souza RJ, Thabane L, Samaan MC. The effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol. Syst Rev 2016;5:101. [PMID: 27301869 DOI: 10.1186/s13643-016-0274-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Müller HL. Hypothalamic involvement in craniopharyngioma-Implications for surgical, radiooncological, and molecularly targeted treatment strategies. Pediatr Blood Cancer 2018;65:e26936. [DOI: 10.1002/pbc.26936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol 2018;178:93-102. [PMID: 29046325 DOI: 10.1530/EJE-17-0707] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
77 Boekhoff S, Bison B, Genzel D, Eveslage M, Otte A, Friedrich C, Flitsch J, Müller HL. Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007. Front Oncol 2021;11:698150. [PMID: 34336685 DOI: 10.3389/fonc.2021.698150] [Reference Citation Analysis]
78 Klages KL, Berlin KS, Cook JL, Merchant TE, Wise MS, Mandrell BN, Conklin HM, Crabtree VM. Health-related quality of life, obesity, fragmented sleep, fatigue, and psychosocial problems among youth with craniopharyngioma. Psychooncology 2021. [PMID: 34859518 DOI: 10.1002/pon.5862] [Reference Citation Analysis]
79 van Iersel L, Meijneke RWH, Schouten-van Meeteren AYN, Reneman L, de Win MM, van Trotsenburg ASP, Bisschop PH, Finken MJJ, Vandertop WP, van Furth WR, van Santen HM. The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort. Pediatr Blood Cancer 2018;65:e26911. [PMID: 29314661 DOI: 10.1002/pbc.26911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
80 Xu D, Wei Q, Li Z, Hu Y, Hu P, Zhao S, Song D, Lei S, Zhang M, Gao Q, Zhang L, Lin F, Zuo Y, Liu X, Feng M, Ma C, Guo F. Development and Validation of Predicting Nomograms for Craniopharyngioma: A Retrospective, Multiple-Center, Cohort Study. Front Oncol 2021;11:691288. [PMID: 34322389 DOI: 10.3389/fonc.2021.691288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Lo AC, Howard AF, Nichol A, Hasan H, Martin M, Heran M, Goddard K. A Cross-Sectional Cohort Study of Cerebrovascular Disease and Late Effects After Radiation Therapy for Craniopharyngioma: CVD After RT in Craniopharyngioma. Pediatr Blood Cancer 2016;63:786-93. [DOI: 10.1002/pbc.25889] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
82 Gupta P, Jalali R. Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life. Curr Neurol Neurosci Rep 2017;17:99. [PMID: 29119343 DOI: 10.1007/s11910-017-0808-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
83 Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. Endocr Connect 2019;8:481-92. [PMID: 30925462 DOI: 10.1530/EC-19-0074] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
84 Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 2016;23:81-9. [PMID: 26574645 DOI: 10.1097/MED.0000000000000214] [Cited by in Crossref: 70] [Cited by in F6Publishing: 19] [Article Influence: 11.7] [Reference Citation Analysis]
85 Ippen FM, Colman H, van den Bent MJ, Brastianos PK. Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet? American Society of Clinical Oncology Educational Book 2018. [DOI: 10.1200/edbk_199247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Müller HL. Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine 2016;51:1-3. [DOI: 10.1007/s12020-015-0800-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
87 Müller HL. Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother 2015;15:1241-4. [PMID: 26523617 DOI: 10.1586/14737175.2015.1100078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
88 Seo Y, Kim YH, Kim JH, Kong DS, Dho YS, Kang H, Kim KM, Kim JW, Park CK. Outcomes of the endoscopic endonasal approach for tumors in the third ventricle or invading the third ventricle. J Clin Neurosci 2021;90:302-10. [PMID: 34275567 DOI: 10.1016/j.jocn.2021.06.012] [Reference Citation Analysis]
89 Qiao N. Excess mortality after craniopharyngioma treatment: are we making progress? Endocrine 2019;64:31-7. [DOI: 10.1007/s12020-018-1830-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM. Very long-term sequelae of craniopharyngioma. Eur J Endocrinol 2017;176:755-67. [PMID: 28325825 DOI: 10.1530/EJE-17-0044] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 7.4] [Reference Citation Analysis]
91 Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL. Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). European Journal of Endocrinology 2018;179:331-41. [DOI: 10.1530/eje-18-0505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.8] [Reference Citation Analysis]
92 Brastianos PK, Santagata S. ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol 2016;174:R139-44. [PMID: 26563980 DOI: 10.1530/EJE-15-0957] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 4.9] [Reference Citation Analysis]
93 Yue Q, Yu Y, Shi Z, Wang Y, Zhu W, Du Z, Yao Z, Chen L, Mao Y. Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. Journal of Neurosurgery 2018;129:27-34. [DOI: 10.3171/2017.4.jns163113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
94 van Deuren S, Boonstra A, van Dulmen-den Broeder E, Blijlevens N, Knoop H, Loonen J. Severe fatigue after treatment for childhood cancer. Cochrane Database Syst Rev 2020;3:CD012681. [PMID: 32124971 DOI: 10.1002/14651858.CD012681.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
95 Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM, Anderson RC, Rosenfeld A, Handler M, Gore L, Foreman N, Hankinson TC. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun 2015;3:30. [PMID: 25990246 DOI: 10.1186/s40478-015-0211-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
96 Müller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 2017;13:299-312. [PMID: 28155902 DOI: 10.1038/nrendo.2016.217] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]